Related Macular Degeneration Programs Toward FDA Engagement and IND-Enabling ActivitiesTargeting Initiation of Phase 1 ...

Agentic AI could reshape drug development. In this interview, Dr. Claudio D’Ambrosio discusses how agentic AI can identify novel drug compounds, improve trial design, and reduce operational ...

Our country is seeing a growth in phase 1 clinical trials conducted by public hospitals to test new drugs and devices.

A burdensome regulatory environment is pushing clinical trials overseas. Jacob Becraft is the co-founder and CEO of Strand Therapeutics.

Clinical Trials suffer due to inherent inefficiencies in manual workflows built on fragmented systems. It's time for a ...

Sponsor-initiated trial closure can abruptly end access despite exceptional individual benefit, underscoring the need for contingency planning for drug supply, follow-on protocols, and ...

Clinical trials are the cornerstone of drug innovation in modern medicine, providing a systematic, evidence-based framework for determining the efficacy and safety of treatments before they reach ...

Discover the impact of digital pathology on drug discovery and biomarker research this International Women’s Day with Dr ...

Researchers have developed a human intestinal cell model that closely mimics the structure and function of the human gut, enabling more precise prediction of drug-induced gastrointestinal toxicity ...

The end of an earnings season can be a great time to discover new stocks and assess how companies are handling the current ...

Discover why biomarkers are critical in modern drug discovery and clinical trials, enabling better target validation.